These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. An active cognitive lifestyle as a potential neuroprotective factor in Huntington's disease. Garcia-Gorro C; Garau-Rolandi M; Escrichs A; Rodriguez-Dechicha N; Vaquer I; Subira S; Calopa M; Martinez-Horta S; Perez-Perez J; Kulisevsky J; Muñoz E; Santacruz P; Ruiz-Idiago J; Mareca C; de Diego-Balaguer R; Camara E Neuropsychologia; 2019 Jan; 122():116-124. PubMed ID: 30563619 [TBL] [Abstract][Full Text] [Related]
11. Longitudinal in vivo MRI in a Huntington's disease mouse model: Global atrophy in the absence of white matter microstructural damage. Steventon JJ; Trueman RC; Ma D; Yhnell E; Bayram-Weston Z; Modat M; Cardoso J; Ourselin S; Lythgoe M; Stewart A; Rosser AE; Jones DK Sci Rep; 2016 Sep; 6():32423. PubMed ID: 27581950 [TBL] [Abstract][Full Text] [Related]
12. Neuroinflammation in Huntington's Disease: New Insights with Lois C; González I; Izquierdo-García D; Zürcher NR; Wilkens P; Loggia ML; Hooker JM; Rosas HD ACS Chem Neurosci; 2018 Nov; 9(11):2563-2571. PubMed ID: 29719953 [TBL] [Abstract][Full Text] [Related]
13. Dynamic functional network connectivity in Huntington's disease and its associations with motor and cognitive measures. Espinoza FA; Liu J; Ciarochi J; Turner JA; Vergara VM; Caprihan A; Misiura M; Johnson HJ; Long JD; Bockholt JH; Paulsen JS; Calhoun VD Hum Brain Mapp; 2019 Apr; 40(6):1955-1968. PubMed ID: 30618191 [TBL] [Abstract][Full Text] [Related]
14. Longitudinal changes in functional connectivity of cortico-basal ganglia networks in manifests and premanifest huntington's disease. Gargouri F; Messé A; Perlbarg V; Valabregue R; McColgan P; Yahia-Cherif L; Fernandez-Vidal S; Ben Hamida A; Benali H; Tabrizi S; Durr A; Lehéricy S Hum Brain Mapp; 2016 Nov; 37(11):4112-4128. PubMed ID: 27400836 [TBL] [Abstract][Full Text] [Related]
15. Functional Magnetic Resonance Imaging in Huntington's Disease. Gregory S; Scahill RI Int Rev Neurobiol; 2018; 142():381-408. PubMed ID: 30409260 [TBL] [Abstract][Full Text] [Related]
16. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease. Ginovart N; Lundin A; Farde L; Halldin C; Bäckman L; Swahn CG; Pauli S; Sedvall G Brain; 1997 Mar; 120 ( Pt 3)():503-14. PubMed ID: 9126061 [TBL] [Abstract][Full Text] [Related]
17. Study protocol of IMAGINE-HD: Imaging iron accumulation and neuroinflammation with 7T-MRI + CSF in Huntington's disease. van de Zande NA; Bulk M; Najac C; van der Weerd L; de Bresser J; Lewerenz J; Ronen I; de Bot ST Neuroimage Clin; 2023; 39():103450. PubMed ID: 37327706 [TBL] [Abstract][Full Text] [Related]
19. Reduced amygdala volumes are related to motor and cognitive signs in Huntington's disease: The IMAGE-HD study. Ahveninen LM; Stout JC; Georgiou-Karistianis N; Lorenzetti V; Glikmann-Johnston Y Neuroimage Clin; 2018; 18():881-887. PubMed ID: 29876272 [TBL] [Abstract][Full Text] [Related]
20. Advances in the understanding of early Huntington's disease using the functional imaging techniques of PET and SPET. Andrews TC; Brooks DJ Mol Med Today; 1998 Dec; 4(12):532-9. PubMed ID: 9866823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]